-
1
-
-
80053635652
-
How I treat extramedullary acute myeloid leukemia
-
1:CAS:528:DC%2BC3MXhtlCgtb%2FO 21795742
-
Bakst RL, Tallman MS, Douer D, Yahalom J. How I treat extramedullary acute myeloid leukemia. Blood. 2011;118:3785-93.
-
(2011)
Blood
, vol.118
, pp. 3785-3793
-
-
Bakst, R.L.1
Tallman, M.S.2
Douer, D.3
Yahalom, J.4
-
2
-
-
83855165809
-
Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease
-
1:CAS:528:DC%2BC3MXhs1ajsbbF 21692072
-
Shihadeh F, Reed V, Faderl S, Medeiros LJ, Mazloom A, Hadziahmetovic M, Kantarjian H, Allen P, Ballas L, Pierce S, Dabaja B. Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease. Cancer. 2012;118:112-7.
-
(2012)
Cancer
, vol.118
, pp. 112-117
-
-
Shihadeh, F.1
Reed, V.2
Faderl, S.3
Medeiros, L.J.4
Mazloom, A.5
Hadziahmetovic, M.6
Kantarjian, H.7
Allen, P.8
Ballas, L.9
Pierce, S.10
Dabaja, B.11
-
3
-
-
84866564593
-
Management of extramedullary leukemia as a presentation of acute myeloid leukemia
-
22956813
-
Slomowitz SJ, Shami PJ. Management of extramedullary leukemia as a presentation of acute myeloid leukemia. J Natl Compr Canc Netw. 2012;10:1165-9.
-
(2012)
J Natl Compr Canc Netw
, vol.10
, pp. 1165-1169
-
-
Slomowitz, S.J.1
Shami, P.J.2
-
4
-
-
84886781221
-
Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia
-
1:CAS:528:DC%2BC3sXhsVyltrrL 24054717
-
Shimizu H, Saitoh T, Hatsumi N, Takada S, Handa H, Jimbo T, Sakura T, Miyawaki S, Nojima Y. Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia. Leuk Res. 2013;37:1477-81.
-
(2013)
Leuk Res
, vol.37
, pp. 1477-1481
-
-
Shimizu, H.1
Saitoh, T.2
Hatsumi, N.3
Takada, S.4
Handa, H.5
Jimbo, T.6
Sakura, T.7
Miyawaki, S.8
Nojima, Y.9
-
5
-
-
84913619549
-
Clinical and pathologic analysis of extramedullary tumors after hematopoietic stem cell transplantation
-
25294373
-
Huang Q, Reddi D, Chu P, Snyder DS, Weisenburger DD. Clinical and pathologic analysis of extramedullary tumors after hematopoietic stem cell transplantation. Hum Pathol. 2014;45:2404-10.
-
(2014)
Hum Pathol
, vol.45
, pp. 2404-2410
-
-
Huang, Q.1
Reddi, D.2
Chu, P.3
Snyder, D.S.4
Weisenburger, D.D.5
-
6
-
-
3843063490
-
Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome
-
1:CAS:528:DC%2BD2cXmt1Ohtb8%3D 15289011
-
Chang H, Brandwein J, Yi QL, Chun K, Patterson B, Brien B. Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome. Leuk Res. 2004;28:1007-11.
-
(2004)
Leuk Res
, vol.28
, pp. 1007-1011
-
-
Chang, H.1
Brandwein, J.2
Yi, Q.L.3
Chun, K.4
Patterson, B.5
Brien, B.6
-
7
-
-
67650034623
-
Enhanced invasiveness of drug-resistant acute myeloid leukemia cells through increased expression of matrix metalloproteinase-2
-
1:CAS:528:DC%2BD1MXovVers74%3D 19449375
-
Song JH, Kim SH, Cho D, Lee IK, Kim HJ, Kim TS. Enhanced invasiveness of drug-resistant acute myeloid leukemia cells through increased expression of matrix metalloproteinase-2. Int J Cancer. 2009;125:1074-81.
-
(2009)
Int J Cancer
, vol.125
, pp. 1074-1081
-
-
Song, J.H.1
Kim, S.H.2
Cho, D.3
Lee, I.K.4
Kim, H.J.5
Kim, T.S.6
-
8
-
-
77953609640
-
The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells
-
20138666
-
Wang C, Chen Z, Li Z, Cen J. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells. Leuk Res. 2010;34:1083-90.
-
(2010)
Leuk Res
, vol.34
, pp. 1083-1090
-
-
Wang, C.1
Chen, Z.2
Li, Z.3
Cen, J.4
-
9
-
-
84877123834
-
Overexpression of amyloid precursor protein in acute myeloid leukemia enhances extramedullary infiltration by MMP-2
-
1:CAS:528:DC%2BC3sXktF2ms7w%3D 23179400
-
Jiang L, Yu G, Meng W, Wang Z, Meng F, Ma W. Overexpression of amyloid precursor protein in acute myeloid leukemia enhances extramedullary infiltration by MMP-2. Tumour Biol. 2013;34:629-36.
-
(2013)
Tumour Biol
, vol.34
, pp. 629-636
-
-
Jiang, L.1
Yu, G.2
Meng, W.3
Wang, Z.4
Meng, F.5
Ma, W.6
-
10
-
-
84904663897
-
Mutant DNMT3A clone evading chemotherapy and infiltrating central nervous system in a patient with molecularly good-risk acute myeloid leukemia
-
24337413
-
Chen YY, Huang CE, Chou HJ, Tsai PS, Lu CH, Chen MF, Lee KD, Chen PT, Lung J, Chen CC. Mutant DNMT3A clone evading chemotherapy and infiltrating central nervous system in a patient with molecularly good-risk acute myeloid leukemia. Ann Hematol. 2014;93:1441-2.
-
(2014)
Ann Hematol
, vol.93
, pp. 1441-1442
-
-
Chen, Y.Y.1
Huang, C.E.2
Chou, H.J.3
Tsai, P.S.4
Lu, C.H.5
Chen, M.F.6
Lee, K.D.7
Chen, P.T.8
Lung, J.9
Chen, C.C.10
-
11
-
-
79960735923
-
Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia
-
1:CAS:528:DC%2BC3MXhtVOqsLnI 21670448
-
Thol F, Damm F, Ludeking A, Winschel C, Wagner K, Morgan M, Yun H, Gohring G, Schlegelberger B, Hoelzer D, et al. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. J Clin Oncol. 2011;29:2889-96.
-
(2011)
J Clin Oncol
, vol.29
, pp. 2889-2896
-
-
Thol, F.1
Damm, F.2
Ludeking, A.3
Winschel, C.4
Wagner, K.5
Morgan, M.6
Yun, H.7
Gohring, G.8
Schlegelberger, B.9
Hoelzer, D.10
-
12
-
-
84862502902
-
Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia
-
1:CAS:528:DC%2BC38XhtVGns7zK 22490330
-
Ribeiro AF, Pratcorona M, Erpelinck-Verschueren C, Rockova V, Sanders M, Abbas S, Figueroa ME, Zeilemaker A, Melnick A, Lowenberg B, et al. Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia. Blood. 2012;119:5824-31.
-
(2012)
Blood
, vol.119
, pp. 5824-5831
-
-
Ribeiro, A.F.1
Pratcorona, M.2
Erpelinck-Verschueren, C.3
Rockova, V.4
Sanders, M.5
Abbas, S.6
Figueroa, M.E.7
Zeilemaker, A.8
Melnick, A.9
Lowenberg, B.10
-
13
-
-
84894245627
-
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
-
1:CAS:528:DC%2BC2cXivVenurY%3D 24522528 4991939
-
Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V, Kennedy JA, Schimmer AD, Schuh AC, Yee KW, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 2014;506:328-33.
-
(2014)
Nature
, vol.506
, pp. 328-333
-
-
Shlush, L.I.1
Zandi, S.2
Mitchell, A.3
Chen, W.C.4
Brandwein, J.M.5
Gupta, V.6
Kennedy, J.A.7
Schimmer, A.D.8
Schuh, A.C.9
Yee, K.W.10
-
14
-
-
84948953284
-
Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse
-
1:CAS:528:DC%2BC28XkvFyqsb8%3D 26438511
-
Garg M, Nagata Y, Kanojia D, Mayakonda A, Yoshida K, Haridas Keloth S, Zang ZJ, Okuno Y, Shiraishi Y, Chiba K, et al. Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse. Blood. 2015;126:2491-501.
-
(2015)
Blood
, vol.126
, pp. 2491-2501
-
-
Garg, M.1
Nagata, Y.2
Kanojia, D.3
Mayakonda, A.4
Yoshida, K.5
Haridas Keloth, S.6
Zang, Z.J.7
Okuno, Y.8
Shiraishi, Y.9
Chiba, K.10
-
15
-
-
79960255863
-
Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
-
1:CAS:528:DC%2BC3MXoslOhsr0%3D 21415852 3202965
-
Walter MJ, Ding L, Shen D, Shao J, Grillot M, McLellan M, Fulton R, Schmidt H, Kalicki-Veizer J, O'Laughlin M, et al. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia. 2011;25:1153-8.
-
(2011)
Leukemia
, vol.25
, pp. 1153-1158
-
-
Walter, M.J.1
Ding, L.2
Shen, D.3
Shao, J.4
Grillot, M.5
McLellan, M.6
Fulton, R.7
Schmidt, H.8
Kalicki-Veizer, J.9
O'Laughlin, M.10
-
16
-
-
84862909358
-
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications
-
1:CAS:528:DC%2BC38XhsVKltL8%3D 22077061
-
Hou HA, Kuo YY, Liu CY, Chou WC, Lee MC, Chen CY, Lin LI, Tseng MH, Huang CF, Chiang YC, et al. DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications. Blood. 2012;119:559-68.
-
(2012)
Blood
, vol.119
, pp. 559-568
-
-
Hou, H.A.1
Kuo, Y.Y.2
Liu, C.Y.3
Chou, W.C.4
Lee, M.C.5
Chen, C.Y.6
Lin, L.I.7
Tseng, M.H.8
Huang, C.F.9
Chiang, Y.C.10
-
17
-
-
33644832818
-
Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia
-
16361619
-
Johnston DL, Alonzo TA, Gerbing RB, Lange BJ, Woods WG. Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia. J Clin Oncol. 2005;23:9172-8.
-
(2005)
J Clin Oncol
, vol.23
, pp. 9172-9178
-
-
Johnston, D.L.1
Alonzo, T.A.2
Gerbing, R.B.3
Lange, B.J.4
Woods, W.G.5
-
18
-
-
84858008504
-
The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations
-
21904384
-
Tiacci E, Spanhol-Rosseto A, Martelli MP, Pasqualucci L, Quentmeier H, Grossmann V, Drexler HG, Falini B. The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations. Leukemia. 2011;26:554-7.
-
(2011)
Leukemia
, vol.26
, pp. 554-557
-
-
Tiacci, E.1
Spanhol-Rosseto, A.2
Martelli, M.P.3
Pasqualucci, L.4
Quentmeier, H.5
Grossmann, V.6
Drexler, H.G.7
Falini, B.8
-
19
-
-
80052939925
-
Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1
-
1:CAS:528:DC%2BC3MXht1OgtbzF 21719597
-
Balusu R, Fiskus W, Rao R, Chong DG, Nalluri S, Mudunuru U, Ma H, Chen L, Venkannagari S, Ha K, et al. Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1. Blood. 2011;118:3096-106.
-
(2011)
Blood
, vol.118
, pp. 3096-3106
-
-
Balusu, R.1
Fiskus, W.2
Rao, R.3
Chong, D.G.4
Nalluri, S.5
Mudunuru, U.6
Ma, H.7
Chen, L.8
Venkannagari, S.9
Ha, K.10
-
20
-
-
84894303664
-
DNMT3A Arg882 mutation drives chronic myelomonocytic leukemia through disturbing gene expression/DNA methylation in hematopoietic cells
-
1:CAS:528:DC%2BC2cXivFamurs%3D 24497509 3932885
-
Xu J, Wang YY, Dai YJ, Zhang W, Zhang WN, Xiong SM, Gu ZH, Wang KK, Zeng R, Chen Z, Chen SJ. DNMT3A Arg882 mutation drives chronic myelomonocytic leukemia through disturbing gene expression/DNA methylation in hematopoietic cells. Proc Natl Acad Sci U S A. 2014;111:2620-5.
-
(2014)
Proc Natl Acad Sci U S A
, vol.111
, pp. 2620-2625
-
-
Xu, J.1
Wang, Y.Y.2
Dai, Y.J.3
Zhang, W.4
Zhang, W.N.5
Xiong, S.M.6
Gu, Z.H.7
Wang, K.K.8
Zeng, R.9
Chen, Z.10
Chen, S.J.11
-
21
-
-
84901787644
-
Oncogenic roles of EMT-inducing transcription factors
-
1:CAS:528:DC%2BC2cXovVaktrs%3D 24875735
-
Puisieux A, Brabletz T, Caramel J. Oncogenic roles of EMT-inducing transcription factors. Nat Cell Biol. 2014;16:488-94.
-
(2014)
Nat Cell Biol
, vol.16
, pp. 488-494
-
-
Puisieux, A.1
Brabletz, T.2
Caramel, J.3
-
22
-
-
4644219519
-
FLT3 mutations in myeloid sarcoma
-
1:CAS:528:DC%2BD2cXovVSrsbk%3D 15352981
-
Ansari-Lari MA, Yang CF, Tinawi-Aljundi R, Cooper L, Long P, Allan RH, Borowitz MJ, Berg KD, Murphy KM. FLT3 mutations in myeloid sarcoma. Br J Haematol. 2004;126:785-91.
-
(2004)
Br J Haematol
, vol.126
, pp. 785-791
-
-
Ansari-Lari, M.A.1
Yang, C.F.2
Tinawi-Aljundi, R.3
Cooper, L.4
Long, P.5
Allan, R.H.6
Borowitz, M.J.7
Berg, K.D.8
Murphy, K.M.9
-
23
-
-
34250721029
-
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas
-
1:CAS:528:DC%2BD2sXms1Wmsr8%3D 17443224
-
Falini B, Lenze D, Hasserjian R, Coupland S, Jaehne D, Soupir C, Liso A, Martelli MP, Bolli N, Bacci F, et al. Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia. 2007;21:1566-70.
-
(2007)
Leukemia
, vol.21
, pp. 1566-1570
-
-
Falini, B.1
Lenze, D.2
Hasserjian, R.3
Coupland, S.4
Jaehne, D.5
Soupir, C.6
Liso, A.7
Martelli, M.P.8
Bolli, N.9
Bacci, F.10
-
24
-
-
81555228423
-
Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia
-
1:CAS:528:DC%2BC3MXhsFyqtrzO 21881046
-
Shen Y, Zhu YM, Fan X, Shi JY, Wang QR, Yan XJ, Gu ZH, Wang YY, Chen B, Jiang CL, et al. Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia. Blood. 2011;118:5593-603.
-
(2011)
Blood
, vol.118
, pp. 5593-5603
-
-
Shen, Y.1
Zhu, Y.M.2
Fan, X.3
Shi, J.Y.4
Wang, Q.R.5
Yan, X.J.6
Gu, Z.H.7
Wang, Y.Y.8
Chen, B.9
Jiang, C.L.10
-
25
-
-
79953176952
-
Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia
-
1:CAS:528:DC%2BC3MXjtVGms7w%3D 21399634
-
Yan XJ, Xu J, Gu ZH, Pan CM, Lu G, Shen Y, Shi JY, Zhu YM, Tang L, Zhang XW, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet. 2011;43:309-15.
-
(2011)
Nat Genet
, vol.43
, pp. 309-315
-
-
Yan, X.J.1
Xu, J.2
Gu, Z.H.3
Pan, C.M.4
Lu, G.5
Shen, Y.6
Shi, J.Y.7
Zhu, Y.M.8
Tang, L.9
Zhang, X.W.10
-
26
-
-
81055130253
-
Deletion of the de novo DNA methyltransferase Dnmt3a promotes lung tumor progression
-
1:CAS:528:DC%2BC3MXhsVOktLbK 22011581 3207684
-
Gao Q, Steine EJ, Barrasa MI, Hockemeyer D, Pawlak M, Fu D, Reddy S, Bell GW, Jaenisch R. Deletion of the de novo DNA methyltransferase Dnmt3a promotes lung tumor progression. Proc Natl Acad Sci U S A. 2011;108:18061-6.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 18061-18066
-
-
Gao, Q.1
Steine, E.J.2
Barrasa, M.I.3
Hockemeyer, D.4
Pawlak, M.5
Fu, D.6
Reddy, S.7
Bell, G.W.8
Jaenisch, R.9
-
27
-
-
84927752378
-
A HIF-1 network reveals characteristics of epithelial-mesenchymal transition in acute promyelocytic leukemia
-
25452766 4249615
-
Percio S, Coltella N, Grisanti S, Bernardi R, Pattini L. A HIF-1 network reveals characteristics of epithelial-mesenchymal transition in acute promyelocytic leukemia. Genome Med. 2014;6:84.
-
(2014)
Genome Med
, vol.6
, pp. 84
-
-
Percio, S.1
Coltella, N.2
Grisanti, S.3
Bernardi, R.4
Pattini, L.5
-
28
-
-
84878372012
-
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
-
Network CGAR. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368:2059-74.
-
(2013)
N Engl J Med
, vol.368
, pp. 2059-2074
-
-
Network, C.G.A.R.1
-
29
-
-
80051709700
-
Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins
-
1:CAS:528:DC%2BC3MXhtFKmsLrJ 21857898 3157343
-
Feng S, Cen J, Huang Y, Shen H, Yao L, Wang Y, Chen Z. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS One. 2011;6:e20599.
-
(2011)
PLoS One
, vol.6
, pp. e20599
-
-
Feng, S.1
Cen, J.2
Huang, Y.3
Shen, H.4
Yao, L.5
Wang, Y.6
Chen, Z.7
-
30
-
-
84863393263
-
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia
-
1:CAS:528:DC%2BC38XktlCqtLs%3D 22417203 3545649
-
Patel JP, Gonen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J, Van Vlierberghe P, Dolgalev I, Thomas S, Aminova O, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med. 2012;366:1079-89.
-
(2012)
N Engl J Med
, vol.366
, pp. 1079-1089
-
-
Patel, J.P.1
Gonen, M.2
Figueroa, M.E.3
Fernandez, H.4
Sun, Z.5
Racevskis, J.6
Van Vlierberghe, P.7
Dolgalev, I.8
Thomas, S.9
Aminova, O.10
-
31
-
-
84927596918
-
DNMT3A mutational status affects the results of dose-escalated induction therapy in acute myelogenous leukemia
-
1:CAS:528:DC%2BC2MXmtVahsbw%3D 25609058 4383675
-
Sehgal AR, Gimotty PA, Zhao J, Hsu JM, Daber R, Morrissette JD, Luger S, Loren AW, Carroll M. DNMT3A mutational status affects the results of dose-escalated induction therapy in acute myelogenous leukemia. Clin Cancer Res. 2015;21:1614-20.
-
(2015)
Clin Cancer Res
, vol.21
, pp. 1614-1620
-
-
Sehgal, A.R.1
Gimotty, P.A.2
Zhao, J.3
Hsu, J.M.4
Daber, R.5
Morrissette, J.D.6
Luger, S.7
Loren, A.W.8
Carroll, M.9
|